Advertisement

Topics

Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

13:19 EDT 28th September 2016 | BioPortfolio

PubMed Articles [376 Associated PubMed Articles listed on BioPortfolio]

Integrated Cardio-Respiratory Control: Insight in Diabetes.

Autonomic dysfunction is a frequent and relevant complication of diabetes mellitus, as it is associated with increased morbidity and mortality. In addition, it is today considered as predictive of the...

Fenofibrate and Diabetic Retinopathy.

Diabetic retinopathy, a common and sight-threatening microvascular complication of diabetes mellitus, is a leading cause of blindness among working-aged adults. Medical therapies including intensive c...

Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease: From Bench to Bedside.

The association of retinal hypoxia with retinal neovascularization has been recognized for decades, causing Michaelson to postulate in 1948 that a factor secreted by hypoxic retina was involved. The i...

Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment: Personal Reminiscences.

We were challenged and delighted when Dr. Sharon Solomon, guest editor of this Retina Supplement, invited us to reminisce about caring for patients with common retinal disorders before there was acces...

Ophthalmologic Outcomes of Children Born Premature Without ROP: Correlations With Gestational Age and Psychomotor Development.

To study ophthalmological outcomes of premature children with no retinopathy of prematurity (ROP) and correlate with neurodevelopmental outcomes.

Per2-Mediated Vascular Dysfunction Is Caused by the Upregulation of the Connective Tissue Growth Factor (CTGF).

Period 2-mutant mice (Per2m/m), which possess a circadian dysfunction, recapitulate the retinal vascular phenotype similar to diabetic retinopathy (DR). The vascular dysfunction in Per2m/m is associat...

Development and Validation of a Diabetic Retinopathy Referral Algorithm Based on Single-Field Fundus Photography.

To develop a simplified algorithm to identify and refer diabetic retinopathy (DR) from single-field retinal images specifically for sight-threatening diabetic retinopathy for appropriate care (ii) to ...

Retinal Sensitivity in Patients with Type I Diabetes without Retinopathy or with Minor Retinal Changes.

Objective: To evaluate the ability of short-wavelength automated perimetry (SWAP) for the detection of visual impairment in patients with type I diabetes without retinopathy or with minor retinal vasc...

Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes.

The aim of this study was to investigate the prevalence of, and traditional and emerging risk factors associated with, retinopathy in a hospital-based population of Australian children and adolescents...

Analysis of Discrepancy Between Diagnostic Clinical Examination Findings and Corresponding Evaluation of Digital Images in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity Study.

As effective treatments for potentially blinding retinopathy of prematurity (ROP) have been introduced, the importance of consistency in findings has increased, especially with the shift toward retina...

News Articles [151 Associated News Articles listed on BioPortfolio]

Speaker reviews use of laser in retinal disease

At Retina 2016, Elias Reichel, MD, focuses on the use of panretinal photocoagulation to treat branch retinal vein occlusion, center-involving diabetic macular edema and proliferative diabetic retinopa...

Financial Incentives Deter Attendance for Diabetic Eye Screening

Contrary to what might be expected, a financial incentive to boost uptake of diabetic retinopathy screening was found to deter invitees from attending. Medscape Medical News

Dr Somdutt Prasad: A Distinguished Moderator and Speaker at the 10th OSWB Academic Meeting

Kolkata, India, September 21, 2016 --(PR.com)-- Noted eye surgeon and retinal specialist of Kolkata Dr Somdutt Prasad is one of the distinguished moderators at the 10th Ophthalmological Society of We...

Retina Group of New York Supports the American Diabetes Association’s Long Island “Step Out: Walk to Stop Diabetes”

Retina Group of New York (RGONY) is proud to be a corporate sponsor of the American Diabetes Association’s Step Out: Walk to Stop Diabetes on Sunday, September 25, 2016 at Jones Beach, Field 5, Long...

UAB experts seek to improve patient adherence recommendations for DR screenings

The prevalence of Type 1 and Type 2 diabetes in the United States is 9.3 percent and expected to increase, along with complications associated with diabetes that include diabetic retinopathy, the lead...

Technological Advancement in Ophthalmic Surgery to Drive Retinal Surgery Devices Market to USD 2.2 Billion by 2020 - iHealthcareAnalyst, Inc.

Maryland Heights, MO, September 17, 2016 --(PR.com)-- Retinal Surgery Devices Market 2013-2020 report estimates the global retinal surgery devices market to reach nearly USD 2.2 Billion in 2020, at a...

Researchers seek better patient adherence recommendations for diabetic retinopathy

The prevalence of Type 1 and Type 2 diabetes in the United States is 9.3 percent and expected to increase, along with complications associated with diabetes that include diabetic retinopathy, the lead...

Dr Somdutt Prasad Invited as a Moderator for the First Prof Krishnendu Sarkar Memorial Oration & CME

Kolkata, India, September 15, 2016 --(PR.com)-- Premier retinal specialist and eye surgeon of Kolkata Dr Somdutt Prasad is invited as a moderator for the first Prof Krishnendu Sarkar Memorial Oration...

'One-Stop Shop' for Diabetic Neuropathy Along With Eye Screening

While diabetic patients are waiting for their eye drops to take effect at retinopathy screening, they could quickly be assessed for early diabetic neuropathy with new devices, at a one-stop shop. ...

Increasing evidence proves value, reliability and benefits of OCT angiography

COPENHAGEN — OCT angiography is establishing itself as a reliable, easy to perform, noninvasive tool for the evaluation of disease progression and treatment-related improvement in retinal diseases s...

Events [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [233 Associated Clinical Trials listed on BioPortfolio]

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Neovascular glaucoma is a potentially blinding condition characterized by the growth of newsless at the anterior part of the eye. This growth is driven by the overexpression of a protein c...

Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

Panretinal photocoagulation (PRP) has been the standard treatment for Proliferative diabetic retinopathy (PDR) since the Diabetic Retinopathy Study demonstrated its benefit nearly 40 years...

Analyzing Retinal Microanatomy in ROP

Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that may impact vision in vulnerable preterm neonates for a lifetime. This study util...

Genetic Markers and Proliferative Diabetic Retinopathy

Type 2 Diabetes (TD2) is the leading cause of new cases of preventable blindness in these countries (and the gold-standard treatment, laser photocoagulation has proven to be effective in p...

Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes

The contribution of OCT- angiography (OCT-A) allows to consider, in a more or less long term, a drastic reduction in the use of fluorescein angiographies in diabetic retinopathy. The accur...

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to contr...

A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema

Diabetic retinopathy(DR) is a sight threatening condition that occurs in persons with diabetes. DR arises as a consequence of damage to the retinal blood vessels and is related to the high...

CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea

Objectives: Main objective: To compare the percentage of patients with new microaneurysm or hard exudates after 12 months between the CPAP group and the control group. Secondary objectives...

Diabetic Retinopathy Screening in Private Practice

Introduction: Diabetic mellitus (DM) is a prevalent disease in Hong Kong (HK) and diabetic retinopathy (DR) is one of the most common complications of DM. Screening for DR is a cost-effect...

Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy

The RECOVERY trial will assess the safety and tolerability of 2 mg intravitreal aflibercept injections (IAI) given monthly (Q4WK) or every 12 weeks (Q12WK) for the treatment of retinal non...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Quick Search
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks